India is ready to produce over 5 billion Covid vaccine doses next year to help the world in the fight against the pandemic, Prime Minister Narendra Modi said at a G-20 Summit session in Rome on Saturday and asserted that it was necessary that the WHO approves Indian vaccines "at the earliest".
A technical advisory group of the UN health agency will meet on November 3 to conduct a final "risk-benefit assessment" for Emergency Use Listing of Covaxin. Bharat Biotech's Covaxin and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India.
The prime minister, in his
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)